Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer

NCT07109817 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Peripheral Neuropathy

Interventions

DRUG: Desloratodine
DRUG: Placebo

Sponsor

Montefiore Medical Center